Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deregulated transcription factors in cancer cell metabolisms and reprogramming
Rajni Kant, Rajesh Manne, Mohammad Anas, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1158-1174
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis
Jingyuan Wen, Xue Lin, Wei Yi, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 26
Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers‐Mediated Photodynamic Therapy
Qing Yu, Xia Li, Juan Wang, et al.
Small (2023) Vol. 20, Iss. 16
Closed Access | Times Cited: 24
FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity
Enni Chen, Jiawei Wu, Jiajia Huang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Current advances in modulating tumor hypoxia for enhanced therapeutic efficacy
Zihan Liu, Xinping Liu, Wei Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 1-27
Open Access | Times Cited: 12
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei-Ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 18
Deregulated transcription factors in the emerging cancer hallmarks
Adria Hasan, Naushad Ahmad Khan, Shahab Uddin, et al.
Seminars in Cancer Biology (2023) Vol. 98, pp. 31-50
Closed Access | Times Cited: 13
Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway
Rongzhen Deng, Yuping Zhu, Keli Liu, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107212-107212
Closed Access | Times Cited: 4
TFAP4 Regulation of MCM5 Activates the PI3K/AKT Pathway to Promote Invasion and Metastasis of Gastric Cancer
Yi‐Wu Yuan, Zhenqi Yue, Qi Zhou, et al.
Digestive Diseases and Sciences (2025)
Closed Access
GATA2 promotes M1 macrophage polarization and inhibits the malignant progression of lung adenocarcinoma through transcription activation-mediated upregulation of KANK3
Shubo Yang, Yuechang Wu, Dubiao Xian
Molecular & Cellular Toxicology (2025)
Closed Access
Association between individual Warburg‐related proteins and prognosis in colorectal cancer
Kelly Offermans, Josien C.A. Jenniskens, Colinda C.J.M. Simons, et al.
The Journal of Pathology Clinical Research (2025) Vol. 11, Iss. 2
Open Access
FLT3 inhibition upregulates OCT4/NANOG to promote maintenance and TKI resistance of FLT3-ITD+ acute myeloid leukemia
Qi Zhou, Zijian Li, Pingping Zhao, et al.
Oncogenesis (2025) Vol. 14, Iss. 1
Open Access
ELK4 induced upregulation of HOMER3 promotes the proliferation and metastasis in glioma via Wnt/β-catenin/EMT signaling pathway
Furong Wang, Hui Zhou, Yu Tian, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
MYCN/MNX1 Axis Drives NSCLC Progression by Inducing Macrophage M2 Polarization and CD8+ T Cell Apoptosis via the Wnt/β‐Catenin Pathway
Chengzhang Cao, Hong-Toan Lai, Shi Yu-zhen
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Closed Access
G-quadruplex in cancer energy metabolism: A potential therapeutic target
Zongqiang Han, Lina Wen
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130810-130810
Closed Access
Myc-associated zinc finger protein: A “double-edged sword” in the malignant process of tumors
Yu Feng, Taiyu Xie, Yu Huang, et al.
New discovery. (2025), pp. 1-9
Closed Access
Doublecortin-like kinase 1, regulated by STIP1 homology and U-box containing protein 1 or Sp1 transcription factor, affects the malignant behaviors and drug sensitivity in adriamycin-resistant breast cancer cells
Li Cheng, Qi Pan, Weidong Guo, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
YTHDC2 manipulates anti-tumoral macrophage polarization and predicts favorable outcomes in triple negative breast cancer
Haojie Jin, Dongbo Zhang, Yufan Ma, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
M6A‐induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C
Peng‐Xiao Hou, Qian Fan, Qin Zhang, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 7
Closed Access | Times Cited: 3
Zinc finger protein 468 up-regulation of TFAM contributes to the malignant growth and cisplatin resistance of breast cancer cells
Zhaoyang Jia, Feng Wang, Gongzhuo Li, et al.
Cell Division (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types
Meetu Rathee, Sheikh Mohammad Umar, Arundhathi Dev, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy
Peng Huang, Feng Wen, Qiu Li
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
CypA/TAF15/STAT5A/miR-514a-3p feedback loop drives ovarian cancer metastasis
Ying Li, Huiwen Yang, An Li, et al.
Oncogene (2024) Vol. 43, Iss. 49, pp. 3570-3585
Closed Access | Times Cited: 2
Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression
William H. Yang, Andrew P. George, Chiung‐Min Wang, et al.
Current Oncology (2023) Vol. 30, Iss. 2, pp. 1614-1625
Open Access | Times Cited: 5
A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer
Lijuan Guo, Wanjun Zhang, Xue Zhang, et al.
Oncogene (2023) Vol. 42, Iss. 35, pp. 2641-2654
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top